Substituted 4-[1H-Imidazol-1-yl] benzamides as antiarrhythmic agents
申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP0290377A1
公开(公告)日:1988-11-09
Novel substituted 4-[1H-imidazol-1-yl]benzamides and their use in the treatment of cardiac arrhythmias especially as Class III or combination Class I/III antiarrhythmic agents is described. Pharmaceutical formulations containing such compounds are also disclosed.
描述了新型取代的 4-[1H-咪唑-1-基]苯甲酰胺及其在治疗心律失常中的用途,特别是作为 III 类或 I/III 类抗心律失常联合药物。还公开了含有此类化合物的药物制剂。
Markovnikov Hydrochlorination of Unactivated Alkenes with FeCl3 via a HAT/XAT Sequence
process using earth-abundant and biocompatible FeCl3 as a chlorine source under extraordinarily mild reaction conditions. The protocol is easy to operate with notable features such as excellent chemoselectivity, remarkable efficiency, a broad substrate scope, and good functional group tolerance. Importantly, the synthetic utility is highlighted by scaled-up reactions, late-stage derivatizations of products